Shares of Genzyme Corp. rose Friday evening on a Wall Street Journal report that the biotech drugmaker is discussing a more lucrative deal with French giant Sanofi-Aventis, which has been unsuccessfully pursuing the company since last July.
All News, Video and Posts related to SECTOR: Health Care
Popular Posts:
- S.1139: A bill to amend the Higher Education Act of … – OpenCongress
- WSJ: Genzyme, Sanofi discuss higher buyout price
- WSJ: Genzyme, Sanofi discuss higher buyout price
- Gen-Probe posts higher 3Q profit
- Sanofi: Not Much Of A Patent Cliff To The Rest of The Decade